Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes
| Image |  |
|---|---|
| Description | scientific article published on 31 October 2019 |
| Author/s |
author: Gian Marco Ghiggeri |
| Publication date | October 31, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |